Neurorehabilitation Devices - Global Strategic Business Report

The global market for Neurorehabilitation Devices is estimated at US$1.6 Billion in 2023 and is projected to reach US$4.5 Billion by 2030, growing at a CAGR of 16.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the neurorehabilitation devices market is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the rising number of stroke and injury cases are significant drivers. Secondly, advancements in neuroscience and rehabilitation technologies are enhancing the effectiveness and adoption of these devices. Thirdly, the growing awareness of the benefits of early and intensive rehabilitation is boosting demand for neurorehabilitation devices.

Additionally, the integration of digital health technologies and remote monitoring is making rehabilitation more accessible and personalized. Furthermore, supportive government policies and funding for research and development in neurorehabilitation are encouraging innovation. Lastly, the expansion of healthcare infrastructure and the increasing availability of specialized rehabilitation centers are further driving market growth.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Neurorobotic Systems segment, which is expected to reach US$2.0 Billion by 2030 with a CAGR of a 18.8%. The Brain Computer Interface segment is also set to grow at 12.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $564.4 Million in 2023, and China, forecasted to grow at an impressive 21.2% CAGR to reach $628.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Neurorehabilitation Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Neurorehabilitation Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Neurorehabilitation Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Laboratories, AlterG, Inc., Biometrics Ltd., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 105 Featured):

• Abbott Laboratories
• AlterG, Inc.
• Biometrics Ltd.
• Bioness Inc.
• BIONIK Laboratories Corp.
• Boston Scientific Corporation
• Ectron Ltd
• Ekso Bionics Holdings Inc.
• Eodyne
• Helius Medical Technologies
• Hocoma AG
• Instead Technologies Ltd.
• Kinestica
• Medtronic plc
• Neofect
• Neuro Rehab VR
• Reha Technology AG
• Rehab-Robotics Company Limited.
• ReWalk Robotics Ltd.
• Rex Bionics Ltd
• Saebo, Inc.
• Tyromotion GmbH